Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Dynegy Inc
DYN | US
17.69
USD2.83
19.04%
DYN | US
Loading StockChartView...
About Dynegy Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
17.69
Open
15.09
High
18.21
Low
14.96
Dyne Therapeutics Inc. a muscle disease company operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1 duchenne muscular dystrophy and facioscapulohumeral dystrophy as well as rare skeletal muscle and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics Inc. was incorporated in 2017 and is headquartered in Waltham Massachusetts.
View LessDYN | US
Risk
87.0
Sharpe
0.43
Luna's Score
58/100
Recommendation
Hold
Luna says (DYN | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
111.7%1 month
87.0%3 months
77.5%6 months
93.5%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.56
Debt to equity
0.03
Debt to assets
0.03
Ent. to EBITDA
-8.87
Ent. to rev.
-
PEG
0.19
Other Fundamentals
EBITDA
-269.47M
MarketCap
1.78B
MarketCap(USD)
1.78B
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-52.46
Short ratio
4.43
Short perc.
10.53
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
4.21
Range1M
4.21
Range3M
9.96
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
2.55
Price X volume
92.75M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -8.87 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 4.56 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 77.49 | 72.80 | Par |
| Debt to Equity | 0.03 | -1.23 | Expensive |
| Debt to Assets | 0.03 | 0.25 | Cheaper |
| Market Cap | 1.78B | 3.66B | Emerging |
